| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-phosphate 5-kinase activity | 8.83e-05 | 3 | 109 | 2 | GO:0000285 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-5-kinase activity | 8.83e-05 | 3 | 109 | 2 | GO:0052810 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 1.38e-04 | 206 | 109 | 7 | GO:0043021 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity | 4.37e-04 | 6 | 109 | 2 | GO:0043813 | |
| GeneOntologyMolecularFunction | RISC complex binding | 4.37e-04 | 6 | 109 | 2 | GO:1905172 | |
| GeneOntologyCellularComponent | FACT complex | 1.61e-04 | 4 | 109 | 2 | GO:0035101 | |
| GeneOntologyCellularComponent | endoplasmic reticulum tubular network membrane | 2.67e-04 | 5 | 109 | 2 | GO:0098826 | |
| GeneOntologyCellularComponent | Golgi membrane | GBF1 MGAT4A ARFGEF2 ARFGEF1 RHBDD2 SMPD4 ATL1 PIKFYVE CSGALNACT2 FIG4 VPS13B PLCE1 | 3.81e-04 | 721 | 109 | 12 | GO:0000139 |
| GeneOntologyCellularComponent | cell projection membrane | 4.29e-04 | 431 | 109 | 9 | GO:0031253 | |
| GeneOntologyCellularComponent | pole plasm | 4.57e-04 | 29 | 109 | 3 | GO:0045495 | |
| GeneOntologyCellularComponent | germ plasm | 4.57e-04 | 29 | 109 | 3 | GO:0060293 | |
| GeneOntologyCellularComponent | P granule | 4.57e-04 | 29 | 109 | 3 | GO:0043186 | |
| GeneOntologyCellularComponent | late endosome | 4.81e-04 | 348 | 109 | 8 | GO:0005770 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | GBF1 MGAT4A ARFGEF2 ARFGEF1 SMPD4 ATP8B1 ATL1 CSGALNACT2 VPS13B | 5.22e-04 | 443 | 109 | 9 | GO:0098791 |
| GeneOntologyCellularComponent | cell leading edge | 1.23e-03 | 500 | 109 | 9 | GO:0031252 | |
| Domain | Sec7_N | 7.28e-07 | 4 | 107 | 3 | IPR032691 | |
| Domain | Sec7_N | 7.28e-07 | 4 | 107 | 3 | PF12783 | |
| Domain | - | 6.61e-05 | 74 | 107 | 5 | 3.40.50.410 | |
| Domain | - | 7.91e-05 | 15 | 107 | 3 | 1.10.1000.11 | |
| Domain | Sec7 | 7.91e-05 | 15 | 107 | 3 | PF01369 | |
| Domain | Sec7_alpha_orthog | 7.91e-05 | 15 | 107 | 3 | IPR023394 | |
| Domain | SEC7 | 9.70e-05 | 16 | 107 | 3 | PS50190 | |
| Domain | Sec7 | 9.70e-05 | 16 | 107 | 3 | SM00222 | |
| Domain | Sec7_dom | 9.70e-05 | 16 | 107 | 3 | IPR000904 | |
| Domain | SHR-BD | 1.94e-04 | 4 | 107 | 2 | IPR009543 | |
| Domain | DCB_dom | 1.94e-04 | 4 | 107 | 2 | IPR032629 | |
| Domain | Sec7_C | 1.94e-04 | 4 | 107 | 2 | IPR015403 | |
| Domain | DUF1981 | 1.94e-04 | 4 | 107 | 2 | PF09324 | |
| Domain | VPS13_C | 1.94e-04 | 4 | 107 | 2 | PF16909 | |
| Domain | VPS13_C | 1.94e-04 | 4 | 107 | 2 | IPR031645 | |
| Domain | DCB | 1.94e-04 | 4 | 107 | 2 | PF16213 | |
| Domain | SHR-BD | 1.94e-04 | 4 | 107 | 2 | PF06650 | |
| Domain | VWF_A | 2.62e-04 | 99 | 107 | 5 | IPR002035 | |
| Domain | Autophagy-rel_C | 3.22e-04 | 5 | 107 | 2 | IPR015412 | |
| Domain | ATG_C | 3.22e-04 | 5 | 107 | 2 | PF09333 | |
| Domain | PIPKc | 8.90e-04 | 8 | 107 | 2 | SM00330 | |
| Domain | - | 8.90e-04 | 8 | 107 | 2 | 3.30.800.10 | |
| Domain | Chorein_N | 8.90e-04 | 8 | 107 | 2 | PF12624 | |
| Domain | PIP5K | 8.90e-04 | 8 | 107 | 2 | PF01504 | |
| Domain | PIPK | 8.90e-04 | 8 | 107 | 2 | PS51455 | |
| Domain | PInositol-4-P-5-kinase_N | 8.90e-04 | 8 | 107 | 2 | IPR027484 | |
| Domain | PInositol-4-P-5-kinase_C | 8.90e-04 | 8 | 107 | 2 | IPR027483 | |
| Domain | VPS13_N | 8.90e-04 | 8 | 107 | 2 | IPR026854 | |
| Domain | - | 8.90e-04 | 8 | 107 | 2 | 3.30.810.10 | |
| Domain | PInositol-4-P-5-kinase_core | 8.90e-04 | 8 | 107 | 2 | IPR002498 | |
| Domain | Ptc/Disp | 1.14e-03 | 9 | 107 | 2 | IPR003392 | |
| Domain | Patched | 1.14e-03 | 9 | 107 | 2 | PF02460 | |
| Domain | SERPIN | 1.23e-03 | 37 | 107 | 3 | PS00284 | |
| Domain | SERPIN | 1.23e-03 | 37 | 107 | 3 | SM00093 | |
| Domain | VWFA | 1.26e-03 | 82 | 107 | 4 | PS50234 | |
| Domain | Serpin | 1.33e-03 | 38 | 107 | 3 | PF00079 | |
| Domain | VWA | 1.38e-03 | 84 | 107 | 4 | SM00327 | |
| Domain | GBP_C | 1.42e-03 | 10 | 107 | 2 | PF02841 | |
| Domain | Serpin_fam | 1.44e-03 | 39 | 107 | 3 | IPR000215 | |
| Domain | WD40_repeat_dom | 1.61e-03 | 297 | 107 | 7 | IPR017986 | |
| Domain | G_GB1_RHD3_dom | 1.73e-03 | 11 | 107 | 2 | IPR030386 | |
| Domain | Guanylate-bd_N | 1.73e-03 | 11 | 107 | 2 | IPR015894 | |
| Domain | Guanylate-bd_C | 1.73e-03 | 11 | 107 | 2 | IPR003191 | |
| Domain | GBP | 1.73e-03 | 11 | 107 | 2 | PF02263 | |
| Domain | G_GB1_RHD3 | 1.73e-03 | 11 | 107 | 2 | PS51715 | |
| Domain | PX | 2.04e-03 | 44 | 107 | 3 | SM00312 | |
| Domain | COS | 2.07e-03 | 12 | 107 | 2 | PS51262 | |
| Domain | COS_domain | 2.07e-03 | 12 | 107 | 2 | IPR017903 | |
| Domain | SSD | 2.43e-03 | 13 | 107 | 2 | IPR000731 | |
| Domain | SSD | 2.43e-03 | 13 | 107 | 2 | PS50156 | |
| Domain | PX | 2.78e-03 | 49 | 107 | 3 | PF00787 | |
| Domain | PX | 2.95e-03 | 50 | 107 | 3 | PS50195 | |
| Domain | - | 3.06e-03 | 333 | 107 | 7 | 2.130.10.10 | |
| Domain | - | 3.12e-03 | 51 | 107 | 3 | 3.30.1520.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.16e-03 | 335 | 107 | 7 | IPR015943 | |
| Domain | Bbox_C | 3.25e-03 | 15 | 107 | 2 | IPR003649 | |
| Domain | BBC | 3.25e-03 | 15 | 107 | 2 | SM00502 | |
| Domain | Phox | 3.30e-03 | 52 | 107 | 3 | IPR001683 | |
| Domain | VWA | 4.07e-03 | 56 | 107 | 3 | PF00092 | |
| Domain | DSRM | 5.22e-03 | 19 | 107 | 2 | SM00358 | |
| Pathway | WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS | 2.64e-06 | 6 | 73 | 3 | M39578 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 8.60e-05 | 17 | 73 | 3 | M2482 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 9.16e-05 | 46 | 73 | 4 | M48317 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.43e-04 | 20 | 73 | 3 | MM15061 | |
| Pathway | REACTOME_MICRORNA_MIRNA_BIOGENESIS | 2.82e-04 | 25 | 73 | 3 | M712 | |
| Pubmed | GBF1 TBC1D5 VPS8 ARFGEF2 ARFGEF1 RHBDD2 POR ATL1 DMXL1 PIKFYVE SNX14 FIG4 VPS13A RMC1 SLC29A1 VPS13B | 5.98e-12 | 504 | 110 | 16 | 34432599 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 23386609 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 18003980 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 11161981 | ||
| Pubmed | The expanded collagen VI family: new chains and new questions. | 3.06e-07 | 5 | 110 | 3 | 23869615 | |
| Pubmed | Developmental regulation of biglycan expression in muscle and tendon. | 6.11e-07 | 6 | 110 | 3 | 16810681 | |
| Pubmed | Three novel collagen VI chains with high homology to the alpha3 chain. | 1.07e-06 | 7 | 110 | 3 | 18276594 | |
| Pubmed | Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI). | 1.07e-06 | 7 | 110 | 3 | 18400749 | |
| Pubmed | 1.70e-06 | 8 | 110 | 3 | 20211803 | ||
| Pubmed | TCTN3 MASP1 SPATA6 HCN1 TBC1D5 ARHGAP26 ANO5 ATP8B1 MICU1 TRIM36 VPS13B GNPAT | 1.91e-06 | 686 | 110 | 12 | 29987050 | |
| Pubmed | Association of a common AGO1 variant with lung cancer risk: a two-stage case-control study. | 3.63e-06 | 10 | 110 | 3 | 20721975 | |
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 3.63e-06 | 10 | 110 | 3 | 15345741 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TRAF3IP2 TCTN3 EDC3 PDE9A APMAP ARHGAP26 RHBDD2 SSRP1 EXOC8 MICU1 METTL9 XPO5 KLHL7 POMP SH3PXD2A ATL2 | 4.16e-06 | 1321 | 110 | 16 | 27173435 |
| Pubmed | EDC3 GBF1 AGO2 APMAP ARFGEF2 POR EXOC8 EEF2 MDN1 CSGALNACT2 STAU2 DDX3Y ATL2 SLC29A1 GNPAT | 4.25e-06 | 1168 | 110 | 15 | 19946888 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | GBF1 APMAP TBC1D5 RHBDD2 POR SMPD4 NCBP1 ATL1 EXOC8 EEF2 XPO5 SLC39A6 ATL2 SLC29A1 GNPAT | 6.05e-06 | 1203 | 110 | 15 | 29180619 |
| Pubmed | TRAF3IP2 COL6A2 TBC1D5 RHBDD2 EXOC8 LIG3 FREM2 DROSHA PIP5K1A GNPAT PLCE1 | 7.15e-06 | 650 | 110 | 11 | 38777146 | |
| Pubmed | MMS22L GBF1 GRWD1 ARFGEF1 SMPD4 NCBP1 SSRP1 EXOC8 EEF2 XPO5 VPS13A | 7.90e-06 | 657 | 110 | 11 | 36180527 | |
| Pubmed | Hijacking components of the cellular secretory pathway for replication of poliovirus RNA. | 9.91e-06 | 2 | 110 | 2 | 17079330 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 26405034 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 23918382 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 19853583 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 17360629 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 10716990 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 18203920 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 26301073 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 18417613 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 27391351 | ||
| Pubmed | Roles for a lipid phosphatase in the activation of its opposing lipid kinase. | 9.91e-06 | 2 | 110 | 2 | 32583743 | |
| Pubmed | Reconstitution of human atlastin fusion activity reveals autoinhibition by the C terminus. | 9.91e-06 | 2 | 110 | 2 | 34817557 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 10212200 | ||
| Pubmed | Tooth morphogenesis and ameloblast differentiation are regulated by micro-RNAs. | 1.67e-05 | 16 | 110 | 3 | 20102707 | |
| Pubmed | 1.67e-05 | 16 | 110 | 3 | 16880404 | ||
| Pubmed | GRWD1 MTERF3 POR SMPD4 SSRP1 DMXL1 MICU1 MDN1 ARHGEF10 GLS STAU2 VPS13A SLC39A6 PIP5K1A WDR12 VPS13B | 1.81e-05 | 1487 | 110 | 16 | 33957083 | |
| Pubmed | Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. | 2.43e-05 | 18 | 110 | 3 | 19047128 | |
| Pubmed | 2.43e-05 | 18 | 110 | 3 | 34893605 | ||
| Pubmed | A crucial role for Arf6 in the response of commissural axons to Slit. | 2.87e-05 | 19 | 110 | 3 | 30674481 | |
| Pubmed | Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability. | 2.97e-05 | 3 | 110 | 2 | 25204870 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 19332778 | ||
| Pubmed | Specific functions of BIG1 and BIG2 in endomembrane organization. | 2.97e-05 | 3 | 110 | 2 | 20360857 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 19037259 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 31250375 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 20840855 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 22028665 | ||
| Pubmed | Amino acid sequence of the triple-helical domain of human collagen type VI. | 2.97e-05 | 3 | 110 | 2 | 3198591 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 16866877 | ||
| Pubmed | Re-evaluation of the roles of DROSHA, Export in 5, and DICER in microRNA biogenesis. | 2.97e-05 | 3 | 110 | 2 | 26976605 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 8489506 | ||
| Pubmed | Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance. | 2.97e-05 | 3 | 110 | 2 | 18366090 | |
| Pubmed | Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas. | 2.97e-05 | 3 | 110 | 2 | 26227789 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 16141002 | ||
| Pubmed | Human atlastin GTPases mediate differentiated fusion of endoplasmic reticulum membranes. | 2.97e-05 | 3 | 110 | 2 | 25773277 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 20301676 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 3665927 | ||
| Pubmed | Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. | 2.97e-05 | 3 | 110 | 2 | 21769619 | |
| Pubmed | Involvement of BIG1 and BIG2 in regulating VEGF expression and angiogenesis. | 2.97e-05 | 3 | 110 | 2 | 31199673 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 24443028 | ||
| Pubmed | Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. | 2.97e-05 | 3 | 110 | 2 | 15563506 | |
| Pubmed | Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals. | 2.97e-05 | 3 | 110 | 2 | 27162341 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 19840946 | ||
| Pubmed | Expression of type VI collagen in the developing mouse heart. | 2.97e-05 | 3 | 110 | 2 | 9520112 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 18950639 | ||
| Pubmed | Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen. | 2.97e-05 | 3 | 110 | 2 | 3348212 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 23047693 | ||
| Pubmed | MicroRNA binding to the HIV-1 Gag protein inhibits Gag assembly and virus production. | 2.97e-05 | 3 | 110 | 2 | 24938790 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 21459131 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 36982625 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 22394132 | ||
| Pubmed | Complexity in regulation of microRNA machinery components in invasive breast carcinoma. | 2.97e-05 | 3 | 110 | 2 | 24574065 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 24801232 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 25068656 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 37655623 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 7780011 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 22766726 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 18832381 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 17556371 | ||
| Pubmed | Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. | 2.97e-05 | 3 | 110 | 2 | 8782832 | |
| Pubmed | Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study. | 2.97e-05 | 3 | 110 | 2 | 12011280 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 34855193 | ||
| Pubmed | Mammalian knock out cells reveal prominent roles for atlastin GTPases in ER network morphology. | 2.97e-05 | 3 | 110 | 2 | 27669642 | |
| Pubmed | 3.57e-05 | 285 | 110 | 7 | 34369648 | ||
| Pubmed | 3.64e-05 | 638 | 110 | 10 | 33239621 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 3.79e-05 | 394 | 110 | 8 | 27248496 | |
| Pubmed | 3.93e-05 | 21 | 110 | 3 | 15014966 | ||
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 4.02e-05 | 197 | 110 | 6 | 29872149 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 11013081 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 12606707 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 12571360 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 26147304 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 26125944 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 22084092 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 26157143 | ||
| Pubmed | Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma. | 5.92e-05 | 4 | 110 | 2 | 22647351 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 20699384 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 15498460 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 8806434 | ||
| Pubmed | Ciliary Hedgehog Signaling Restricts Injury-Induced Adipogenesis. | 5.92e-05 | 4 | 110 | 2 | 28709001 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 18761340 | ||
| Pubmed | Fas-associated factor (FAF1) is required for the early cleavage-stages of mouse embryo. | 5.92e-05 | 4 | 110 | 2 | 18303090 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 32770606 | ||
| Pubmed | Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen. | 5.92e-05 | 4 | 110 | 2 | 15194424 | |
| Interaction | EDNRB interactions | 2.01e-06 | 39 | 108 | 5 | int:EDNRB | |
| Interaction | RHOF interactions | GBF1 GRWD1 TBC1D5 ARFGEF2 POR SSRP1 PIKFYVE LIG3 MDN1 XPO5 VPS13A SLC39A6 PIP5K1A SLC29A1 VPS13B | 3.02e-06 | 673 | 108 | 15 | int:RHOF |
| Interaction | RAB9A interactions | TBC1D5 VPS8 ARFGEF2 ARFGEF1 POR SMPD4 ATL1 DMXL1 PIKFYVE SNX14 VPS13A SLC39A6 SLC29A1 VPS13B | 3.58e-06 | 595 | 108 | 14 | int:RAB9A |
| Interaction | RAB7A interactions | TCTN3 GBF1 TBC1D5 VPS8 ARFGEF2 ARFGEF1 RHBDD2 POR ATL1 DMXL1 PIKFYVE SNX14 FIG4 VPS13A RMC1 SLC29A1 VPS13B | 4.70e-06 | 886 | 108 | 17 | int:RAB7A |
| Interaction | NPTN interactions | 1.89e-05 | 278 | 108 | 9 | int:NPTN | |
| Interaction | GPR17 interactions | 2.17e-05 | 283 | 108 | 9 | int:GPR17 | |
| Interaction | CSGALNACT1 interactions | 2.39e-05 | 64 | 108 | 5 | int:CSGALNACT1 | |
| Interaction | SIGLECL1 interactions | 3.27e-05 | 113 | 108 | 6 | int:SIGLECL1 | |
| Interaction | GPR182 interactions | MMS22L GBF1 ARFGEF2 ARFGEF1 SMPD4 SNX14 MDN1 XPO5 SLC39A6 ATL2 GNPAT | 3.32e-05 | 455 | 108 | 11 | int:GPR182 |
| Interaction | GPR45 interactions | 3.43e-05 | 300 | 108 | 9 | int:GPR45 | |
| Interaction | RAB4A interactions | TBC1D5 VPS8 ARFGEF2 ARFGEF1 POR SMPD4 DMXL1 PIKFYVE VPS13A SLC39A6 VPS13B | 3.46e-05 | 457 | 108 | 11 | int:RAB4A |
| Interaction | NELFA interactions | 1.11e-04 | 88 | 108 | 5 | int:NELFA | |
| Interaction | HCST interactions | 1.19e-04 | 205 | 108 | 7 | int:HCST | |
| Interaction | SRGAP1 interactions | 1.37e-04 | 92 | 108 | 5 | int:SRGAP1 | |
| Interaction | RAB11A interactions | GBF1 TBC1D5 VPS8 ARFGEF2 ARFGEF1 SMPD4 PTCH1 DMXL1 XPO5 ARHGEF10 VPS13A SLC39A6 SLC29A1 VPS13B | 1.39e-04 | 830 | 108 | 14 | int:RAB11A |
| Interaction | ATG9A interactions | 1.40e-04 | 445 | 108 | 10 | int:ATG9A | |
| Interaction | FPR1 interactions | 1.41e-04 | 147 | 108 | 6 | int:FPR1 | |
| Interaction | PIKFYVE interactions | 1.49e-04 | 50 | 108 | 4 | int:PIKFYVE | |
| Interaction | ELOVL5 interactions | 1.51e-04 | 364 | 108 | 9 | int:ELOVL5 | |
| Interaction | CHN2 interactions | 1.75e-04 | 97 | 108 | 5 | int:CHN2 | |
| Interaction | CD40 interactions | 1.76e-04 | 153 | 108 | 6 | int:CD40 | |
| GeneFamily | Serpin peptidase inhibitors | 2.75e-04 | 37 | 62 | 3 | 739 | |
| GeneFamily | Collagens | 5.25e-04 | 46 | 62 | 3 | 490 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GBF1 AGO2 ARFGEF1 ATP8B1 TDRD7 PIKFYVE SEC24D MDN1 ARHGEF10 STAU2 VPS13A PIP5K1A DMD VPS13B PLCE1 | 2.09e-06 | 856 | 107 | 15 | M4500 |
| Coexpression | GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP | 1.68e-05 | 197 | 107 | 7 | M3133 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 2.47e-05 | 84 | 107 | 5 | M13008 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 2.61e-05 | 85 | 107 | 5 | M10575 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.54e-06 | 179 | 110 | 6 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.90e-06 | 186 | 110 | 6 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.80e-06 | 190 | 110 | 6 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.80e-06 | 190 | 110 | 6 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.80e-06 | 190 | 110 | 6 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.28e-06 | 192 | 110 | 6 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.53e-06 | 193 | 110 | 6 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.53e-06 | 193 | 110 | 6 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.31e-06 | 196 | 110 | 6 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.31e-06 | 196 | 110 | 6 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | ASK454-Epithelial-Type_2|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.22e-05 | 136 | 110 | 5 | ff9a5e111993fdb3ac64c5ef269e3460ff994517 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 167 | 110 | 5 | 7f3224af9b30082b927a822b91f96e0c88151b4e | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 167 | 110 | 5 | a21a2b301d0a3d7a41e605f7a3c37548962a331d | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 167 | 110 | 5 | 0e746483773bde6582874a33591ab2a578d724eb | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 6.27e-05 | 169 | 110 | 5 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-05 | 170 | 110 | 5 | b4f2c05db2c2591561fd42febc72eed3b5e8f9fb | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.45e-05 | 180 | 110 | 5 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.13e-05 | 183 | 110 | 5 | 310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 183 | 110 | 5 | b0b835f3b1de1bd46a47e1b805aa8994cd3a4e3e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.13e-05 | 183 | 110 | 5 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.13e-05 | 183 | 110 | 5 | fef51dcf180e6d4e136362c7e140ec5ef372e6d0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 187 | 110 | 5 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 188 | 110 | 5 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-04 | 189 | 110 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-04 | 190 | 110 | 5 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-04 | 190 | 110 | 5 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-04 | 190 | 110 | 5 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | proximal-Hematologic-Platelet/Megakaryocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 192 | 110 | 5 | 522d1bb15edf1d6006b80289bd3baadb99584ae8 | |
| ToppCell | proximal-3-Hematologic-Platelet/Megakaryocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 192 | 110 | 5 | f5f83dec37dff32a0c471cb05d23d13b0b0ad0c9 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.14e-04 | 192 | 110 | 5 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | proximal-Hematologic-Platelet/Megakaryocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 192 | 110 | 5 | 57899a905ca3e336bb7f31edc6418a2546b9891a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 192 | 110 | 5 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 192 | 110 | 5 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-04 | 192 | 110 | 5 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-04 | 193 | 110 | 5 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-04 | 193 | 110 | 5 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 194 | 110 | 5 | c9ebdcc2ea600975dade68a41fa65d1f8a5a5926 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 194 | 110 | 5 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 194 | 110 | 5 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 196 | 110 | 5 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.35e-04 | 199 | 110 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-04 | 199 | 110 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Neuronal-Inhibitory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | 9ff8647e2de0b538e15929dca88ebb20ff7ab043 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.38e-04 | 200 | 110 | 5 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.38e-04 | 200 | 110 | 5 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.38e-04 | 200 | 110 | 5 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 109 | 110 | 4 | cc43c221487a712546917cc3253c158a1fc1fd7a | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 109 | 110 | 4 | 0d4128af237afcc0adb4dfdd206fa3ddbe5b0e86 | |
| Disease | alpha-1-antitrypsin measurement | 3.94e-06 | 9 | 108 | 3 | EFO_0008327 | |
| Disease | hereditary spastic paraplegia 3A (implicated_via_orthology) | 3.97e-05 | 3 | 108 | 2 | DOID:0110791 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 3.97e-05 | 3 | 108 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | Ullrich congenital muscular dystrophy | 7.93e-05 | 4 | 108 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 7.93e-05 | 4 | 108 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 7.93e-05 | 4 | 108 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 7.93e-05 | 4 | 108 | 2 | C0410179 | |
| Disease | Bethlem myopathy (is_implicated_in) | 7.93e-05 | 4 | 108 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 7.93e-05 | 4 | 108 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | acute myelomonocytic leukemia (is_implicated_in) | 7.93e-05 | 4 | 108 | 2 | DOID:0081082 (is_implicated_in) | |
| Disease | Bilateral Wilms Tumor | 1.63e-04 | 29 | 108 | 3 | C2930471 | |
| Disease | cortical thickness | TBC1D5 ARFGEF2 PTCH1 PXK FAF1 XPO5 SH3PXD2A GLS STAU2 ASTN2 AGBL2 TRIM36 PLCE1 | 2.18e-04 | 1113 | 108 | 13 | EFO_0004840 |
| Disease | total blood protein measurement | 2.52e-04 | 449 | 108 | 8 | EFO_0004536 | |
| Disease | septic shock | 2.75e-04 | 7 | 108 | 2 | EFO_0006834 | |
| Disease | alpha-1-antichymotrypsin complex measurement | 2.75e-04 | 7 | 108 | 2 | EFO_0008018 | |
| Disease | Nephroblastoma | 3.12e-04 | 36 | 108 | 3 | C0027708 | |
| Disease | small vessel stroke | 4.35e-04 | 96 | 108 | 4 | EFO_1001504 | |
| Disease | mood instability measurement | 1.28e-03 | 128 | 108 | 4 | EFO_0008475 | |
| Disease | serum alanine aminotransferase measurement | GBF1 ANO5 FAM227B ATP8B1 PTCH1 SERPINA6 SERPINA2 RMC1 AGBL2 PLCE1 | 1.34e-03 | 869 | 108 | 10 | EFO_0004735 |
| Disease | Yu-Zhi constitution type | 1.35e-03 | 15 | 108 | 2 | EFO_0007638 | |
| Disease | aspartate aminotransferase measurement | TBC1D5 ANO5 FAM227B ATP8B1 PTCH1 SERPINA6 SERPINA2 PXK ASTN2 PLCE1 | 1.80e-03 | 904 | 108 | 10 | EFO_0004736 |
| Disease | FEV/FEC ratio | COL6A3 PDE9A HCN1 ARHGAP26 DGKD FAM227B PTCH1 FAF1 FREM2 KLHL7 SH3PXD2A ASTN2 | 1.80e-03 | 1228 | 108 | 12 | EFO_0004713 |
| Disease | neuroticism measurement | MMS22L AGO2 CALB2 HCN1 PTCH1 ARHGEF10L NEU2 ASTN2 AGBL2 SSX3 | 1.87e-03 | 909 | 108 | 10 | EFO_0007660 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.02e-03 | 145 | 108 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | stomach cancer (is_implicated_in) | 2.37e-03 | 72 | 108 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | cortisol measurement | 2.42e-03 | 20 | 108 | 2 | EFO_0005843 | |
| Disease | forced expiratory volume | 2.48e-03 | 789 | 108 | 9 | EFO_0004314 | |
| Disease | executive function measurement | 2.65e-03 | 376 | 108 | 6 | EFO_0009332 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.69e-03 | 157 | 108 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | CCL24 measurement | 2.92e-03 | 22 | 108 | 2 | EFO_0009418 | |
| Disease | triacylglycerol 58:9 measurement | 2.92e-03 | 22 | 108 | 2 | EFO_0010443 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FMSIPLSRKDAFFQI | 236 | Q96M60 | |
| LQFNKFRVPTFLSMD | 236 | Q8N5Z0 | |
| RFPQFILLLQDMLKN | 566 | O15013 | |
| RFPQFILLLQDMLKN | 461 | Q9HCE6 | |
| QKPRFLEFFTQVMLK | 1331 | Q96N23 | |
| LRDFIFKNPAISEMV | 1421 | Q96N23 | |
| HLTPEFFLIQNFVKM | 426 | Q8NHU2 | |
| FFLIQNFVKMVPFNT | 431 | Q8NHU2 | |
| INEETMPAKRFNLFL | 41 | Q75V66 | |
| VFRIFDNMKLPEQQT | 1431 | Q9Y6D6 | |
| FLRMKQVKIFPSCLF | 1596 | Q7Z2Y8 | |
| RIVFRIFDNMKLPEQ | 1376 | Q9Y6D5 | |
| FTLRLVQPKRAFDMI | 186 | Q8TF64 | |
| FKLFSQETVMKFVPR | 346 | Q9HDC9 | |
| LQDVSMKFRLFQKPA | 1451 | P11532 | |
| MEVFLQQLRKSFEQP | 406 | Q9Y485 | |
| MTFRENNFIKDFPQL | 796 | O75129 | |
| TFIPMNLFEQFKRAA | 106 | O43520 | |
| RTIKLQANFFEMDIP | 36 | Q9UKV8 | |
| LTQAFRRKFVIPDFM | 211 | O94925 | |
| QAPDLTLIVEFIFMF | 301 | Q9UM21 | |
| HQFLMDTIFQPFLKD | 5266 | Q9NU22 | |
| MFVRKSQFRLPFKAT | 511 | P16435 | |
| QKNLFLVIFQRFIMI | 706 | Q09161 | |
| FLRDEQAQMKPIFSF | 196 | Q9BQ67 | |
| FFSFLKSQRMSQVVP | 721 | Q6ZRQ5 | |
| FSQERQMLQTLKFLP | 181 | Q9BXM9 | |
| LLFNNTRPVMVFTKQ | 1581 | Q5SZK8 | |
| LSTPQRNFEIAFKMF | 216 | Q9BPX6 | |
| KPFILTRNMAQAKVF | 241 | P78318 | |
| TAQIGFIKFVLIPMF | 511 | O76083 | |
| MFVFSPDQFQRLLKI | 126 | Q9H1A3 | |
| NRQPFMVDILAKVRF | 221 | Q8IXQ5 | |
| DVQVILFLPNFVKML | 361 | Q96F86 | |
| MSLAFKIFFPQTLRA | 1 | P49916 | |
| TNQPELQVMIFIFLF | 16 | Q8NGE1 | |
| FKLLMFPESRIFQAE | 251 | Q8IYI6 | |
| FQRFMCNTVFKKIPL | 441 | Q99755 | |
| FRVAKVFAQPNLAEM | 506 | Q9NXE4 | |
| MEFKAVQQVQRLPFL | 81 | Q9Y244 | |
| EIVFLMFTLKQAFPA | 361 | Q9Y3R4 | |
| QFTKMFTLNIRRKPQ | 426 | P36888 | |
| LKQMPRLEVQSFLDF | 1876 | Q9Y2I7 | |
| KYQTVMFNRPFLVII | 386 | P20848 | |
| IPFESFTLMKVFQLE | 146 | Q8N6G5 | |
| PNFVTAMLSKLRFEV | 481 | O60741 | |
| FTFEFLMRVIFCPNK | 256 | P48547 | |
| MEETFLKPFQSLIFL | 201 | Q8WXF7 | |
| LFFTTIMQNFRFKSP | 451 | Q16696 | |
| KFGLLNIVMEPFFKR | 256 | O15228 | |
| FDQMFQRFGSPIIIL | 361 | Q92562 | |
| FPFVKTFINKMINSL | 46 | A8TX70 | |
| RPFLMFIVDNNILFL | 386 | P05154 | |
| FLMRKVAVFFSNTPT | 2506 | P12111 | |
| LLFHMKQFVPQFISQ | 66 | P12110 | |
| IYQKPFQTLMFLIRD | 231 | Q8NHH9 | |
| AQLLRDIFVFKVLPM | 486 | Q5U5Z8 | |
| KQFLQRFPETLMEIE | 591 | P48740 | |
| RFKQLLNPAQVFDLM | 341 | Q16760 | |
| VDMVQLLFTRLPQFK | 186 | Q92538 | |
| RPTQSFVKFMAQQIF | 1191 | Q9ULL0 | |
| MSRLLPVQENFLLKF | 176 | P22676 | |
| QLILDPIFKVFDAIM | 291 | P13639 | |
| RTQKTDQFPLFLIIM | 441 | Q9UNN5 | |
| ATFPKEIQMLARDFL | 381 | O15523 | |
| ILRFNQPFIIMIFDH | 376 | P08185 | |
| AQMVRKAPFLLNFSV | 241 | Q96E29 | |
| LFFVTNTIPKMLVNF | 71 | P47884 | |
| LFFVTNTIPKMLVNF | 71 | P58170 | |
| MNVCFFPRLKEFILN | 1241 | Q9NRR4 | |
| QPFTLVTIGMQKFFI | 631 | Q9NQ86 | |
| IFESQRMKFSEIPQR | 346 | Q96GM5 | |
| LPQQRKMAEIFKTVF | 1491 | Q9P212 | |
| KSIRFIVFNPSFVFM | 636 | Q6ZW05 | |
| MIFQPQLFKDSITRE | 101 | A1A4F0 | |
| RKMFEFVEPLLAFLQ | 191 | Q9UNA1 | |
| VVFNFAMVLLIFPAI | 581 | Q13635 | |
| ILPSFMRNKRVTDFQ | 66 | Q99909 | |
| TEDPQLQVLLFMFLF | 16 | A6NDL8 | |
| NEFISPMEKLFRVIA | 691 | Q8N3P4 | |
| MFRKLPFQAVTAQLA | 1011 | Q8NHU6 | |
| FKQQTIRELFDMPLE | 2201 | Q6ZRS2 | |
| KQREQPEMVFRQFLV | 991 | O94855 | |
| KVQLDALPFFVITMI | 131 | Q99808 | |
| VPLMNRVFFKFLLSF | 346 | Q13433 | |
| RLFLLPHKDQRQMFF | 241 | Q08945 | |
| FIKQGSMNFRFIPVL | 506 | O43734 | |
| SMNFRFIPVLFPNAK | 511 | O43734 | |
| MNALFVQFAEVFPLK | 36 | Q8NCS4 | |
| FVFRPISANAKLVMN | 251 | Q96RL7 | |
| PVNFFRKDFMLLSND | 561 | Q96PX8 | |
| LVFEIALKRNMPVSF | 211 | Q9NUL3 | |
| LLFRFMNFLKQEGAV | 346 | Q9Y5W7 | |
| FFKQIFGDQALMRPT | 641 | Q96DM3 | |
| QTFPFSLMRRISVFK | 216 | Q6NTF9 | |
| KFFDLQMQLLDKFPI | 46 | Q5TCZ1 | |
| LRTATNVRVIFPFMK | 326 | Q8IZM8 | |
| SPVFKTVLERMQRFF | 826 | Q9HAV4 | |
| IALQQVSMFFRSEPK | 131 | Q7Z7A4 | |
| AAIDLVNFMFILFPV | 96 | Q2T9K0 | |
| FLARAKFIPLMIREQ | 296 | A6NIE6 | |
| NKTFNLMRFIFRTDP | 76 | Q494X3 | |
| NTNRAPEKIVTFKMF | 3376 | Q7Z7G8 | |
| FPEMQFFQQENVRKI | 171 | Q92609 | |
| VEFDFLIKGQFLRMP | 51 | Q9GZL7 | |
| MRTPQLALLQVFFLV | 1 | Q6NUS6 | |
| PFLFSKELIVFQMQR | 216 | O15016 | |
| FVLMFLLRKINSEPL | 71 | Q02223 | |
| MLFNQFPGFKEVRLV | 226 | P09012 | |
| FPLVFNARMVFEKVF | 51 | Q9NWH7 | |
| LGFPARFLDFKIQNM | 281 | Q6SJ96 | |
| LANFITPMIFAKIIR | 416 | Q7Z402 | |
| QARMKTPFFIFNLAE | 591 | Q9NX78 | |
| EELFMQIEALFPQKF | 196 | Q5FWF4 |